|
業務類別
|
Biotechnology |
|
業務概覽
|
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others. |
| 公司地址
| EPFL Innovation Park, Building B, Lausanne, CHE, 1015 |
| 電話號碼
| +41 213459121 |
| 傳真號碼
| +41 213459120 |
| 公司網頁
| https://www.acimmune.com |
| 員工數量
| 161 |
| Mr. Christopher Roberts |
Chief Financial Officer |
-- |
13/03/2026 |
| Mr. Mark Danton |
Executive Vice President, Information Systems and Artificial Intelligence |
-- |
13/03/2026 |
| Dr. Francesca Capotosti, PhD |
Vice President, Research |
-- |
13/03/2026 |
| Dr. Matthias Maurer, PhD |
Senior Vice President and General Counsel |
-- |
13/03/2026 |
| Professor Dr. Andrea Pfeifer, PhD |
Chief Executive Officer and Director |
-- |
13/03/2026 |
| Dr. Olivier Sol, M.D. |
Vice President and Clinical Safety Officer |
-- |
13/03/2026 |
| Mr. Piergiorgio Donati |
Chief Technical Operations Officer |
-- |
13/03/2026 |
| Mr. Howard Donovan |
Chief Human Resources Officer |
-- |
13/03/2025 |
| Dr. Julien Rongere, PhD |
Senior Vice President, Regulatory Affairs and Quality Assurance |
-- |
13/03/2026 |
| Dr. Bojana Portmann, PhD |
Vice President, IP and Business Development |
-- |
13/03/2026 |
| Dr. Gunther Staffler, PhD |
Executive Vice President, Development |
-- |
13/03/2026 |
| Dr. Gary Waanders, PhD |
Senior Vice President, Investor Relations and Corporate Communications |
-- |
13/03/2026 |
|
|
| Ms. Renee Aguiar-Lucander |
Director |
13/03/2026 |
| Professor Dr. Monika Butler, PhD |
Vice Chairman of the Board |
13/03/2026 |
| Professor Dr. Andrea Pfeifer, PhD |
Chief Executive Officer and Director |
13/03/2026 |
| Dr. Roy Twyman, M.D. |
Independent Director |
13/03/2026 |
| Dr. Martin Zugel |
Chairman of the Board |
13/03/2026 |
| Professor Dr. Carl June, M.D. |
Independent Director |
13/03/2026 |
|
|
|
|
